7:32 am Cytokinetics announces top-line results from BENEFIT-ALS; BENEFIT-ALS did not achieve its primary efficacy endpoint; secondary efficacy analyses of the effect of tirasemtiv on respiratory function and other measures of skeletal musc – HedgeChatter

7:32 am Cytokinetics announces top-line results from BENEFIT-ALS; BENEFIT-ALS did not achieve its primary efficacy endpoint; secondary efficacy analyses of the effect of tirasemtiv on respiratory function and other measures of skeletal musc

28 Apr

7:32 am Cytokinetics announces top-line results from BENEFIT-ALS; BENEFIT-ALS did not achieve its primary efficacy endpoint; secondary efficacy analyses of the effect of tirasemtiv on respiratory function and other measures of skeletal musc

Bystocknews CYTK, stock Comments Off

View todays social media effects on CYTK

View the latest stocks trending across Twitter. Click to view dashboard

See who Cytokinetics is hiring next, click here to view

Author